Adverse events during anti-TNFα therapies in IBD (Excluding Infections and Malignancies): When to stop, continue, or switch therapies

Priya Sehgal, Jean Frederic Colombel, Neeraj Narula

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Adverse events during anti-TNFα therapies in IBD (Excluding Infections and Malignancies): When to stop, continue, or switch therapies'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science